Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells

Human Gene Therapy

Volumn 15, Issue 12, 2004, Pages 1207-1218

  Zhong, Li ^a   Li, Weiming ^a   Yang, Zuocheng ^a   Qing, Keyun ^a   Tan, Mengqun ^b   Hansen, Jonathan ^a   Li, Yanjun ^a   Chen, Linyuan ^a   Chan, Rebecca J ^a   Bischof, Daniela ^a   Maina, Njeri ^a   Weigel Kelley, Kirsten A ^a   Zhao, Weihong ^a   Larsen, Steven H ^a   Yoder, Mervin C ^a   Shou, Weinian ^a   Srivastava, Arun ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central South University   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DEOXYRIBONUCLEASE I; DRUG CARRIER; HYDROXYUREA; PARVOVIRUS VECTOR; SINGLE STRANDED DNA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; NONHUMAN; SIGNAL TRANSDUCTION; VIRION; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; MURINAE; PARVOVIRUS;

EID: 19944405059     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2004.15.1207     Document Type: Article

References (74)

1. AITKEN, M.L., MOSS, R.B., WALTZ, D.A., DOVEY, M.E., TONELLI, M.R., MCNAMARA, S.C., GIBSON, R.L., RAMSEY, B.W., CARTER, B.J., and REYNOLDS, T.C. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12, 1907-1916.
2. ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1997). Transfer of contaminations in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum. Gene Ther. 8, 1911-1920.
3. BARTLETT, J.S., WILCHER, R., and SAMULSKI, R.J. (2000). Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74, 2777-2785.
4. BERNS, K.I., and GIRAUD, C. (1996). Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218, 1-23.
5. CARTER, B.J., and FLOTTE, T.R. (1996). Development of adeno-associated virus vectors for gene therapy of cystic fibrosis. Curr. Top. Microbiol. Immunol. 218, 119-144.
6. CHATTERJEE, S., LU, D., PODSAKOFF, G., and WONG, K.K., JR. (1995). Strategies for efficient gene transfer into hematopoietic cells: The use of adeno-associated virus vectors in gene therapy. Ann. N.Y. Acad. Sci. 770, 79-90.
7. CHATTERJEE, S., LI, W., WONG, C.A., FISHER-ADAMS, G., LU, D., GUHA, M., MACER, J.A., FORMAN, S.J., and WONG, K.K., Jr. (1999). Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93, 1882-1894.
8. CZAR, M.J., OWENS-GRILLO, J.K., DITTMAR, K.D., HUTCHISON, K.A., ZACHAREK, A.M., LEACH, K.L., DEIBEL, M.R., Jr., and PRATT, W.B. (1994). Characterization of the protein-protein interactions determining the heat shock protein (hsp90·hsp70·hsp56) heterocomplex. J. Biol. Chem. 269, 11155-11161.
9. CZAR, M.J., LYONS, R.H., WELSH, M.J., RENOIR, J.M., and PRATT, W.B. (1995). Evidence that the FK506-binding protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol. Endocrinol. 9, 1549-1560.
10. DE HAAN, G., WEERSING, E., DONTJE, B., VAN OS, R., BYSTRYKH, L.V., VELLENGA, E., and MILLER, G. (2003). In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev. Cell 4, 241-251.
11. DUAN, D., LI, Q., KAO, A.W., YUE, Y., PESSIN, J.E., and ENGELHARDT, J.F. (1999). Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73, 10371-10376.
12. DUAN, D., YUE, Y., YAN, Z., YANG, J., and ENGELHARDT, J.F. (2000). Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J. Clin. Invest. 105, 1573-1587.
13. EINERHAND, M.P., ANTONIOU, M., ZOLOTUKHIN, S., MUZYCZKA, N., BERNS, K.I., GROSVELD, F., and VALERIO, D. (1995). Regulated high-level human β-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther. 2, 336-343.
14. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
15. FISHER, K.J., GAO, G.P., WEITZMAN, M.D., DEMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
16. FLOTTE, T., CARTER, B., CONRAD, C., GUGGINO, W., REYNOLDS, T., ROSENSTElN, B., TAYLOR, G., WALDEN, S., and WETZEL, R. (1996). A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7, 1145-1159.
17. FLOTTE, T.R., AFIONE, S.A., CONRAD, C., MCGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 90, 10613-10617.
18. GALIGNIANA, M.D., RADANYI, C., RENOIR, J.M., HOUSLEY, P.R., and PRATT, W.B. (2001). Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J. Biol. Chem. 276, 14884-14889.
19. HANSEN, J., QING, K., KWON, H.J., MAH, C., and SRIVASTAVA, A. (2000). Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol. 74, 992-996.
20. HANSEN, J., QING, K., and SRIVASTAVA, A. (2001a). Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75, 4080-4090.
21. HANSEN, J., QING, K., and SRIVASTAVA, A. (2001b). Infection of purified nuclei by adeno-associated virus. Mol. Ther. 4, 289-296.
22. HARGROVE, P.W., VANIN, E.F., KURTZMAN, G.J., and NIENHUIS, A.W. (1997). High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3′ γ-globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89, 2167-2175.
23. KAPLITT, M.G., LEONE, P., SAMULSKl, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8, 148-154.
24. KAPLITT, M.G., XIAO, X., SAMULSKI, R.J., LI, J., OJAMAA, K., KLEIN, I.L., MAKIMURA, H., KAPLITT, M.J., STRUMPF, R.K., and DIETHRICH, E.B. (1996). Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann. Thorac. Surg. 62, 1669-1676.
25. KAY, M.A., MANNO, C.S., RAGNI, M.V., LARSON, P.J., COUTO, L.B., MCCLELLAND, A., GLADER, B., CHEW, A.J., TAI, S.J., HERZOG, R.W., ARRUDA, V., JOHNSON, F., SCALLAN, C., SKARSGARD, E., FLAKE, A.W., and HIGH, K.A. (2000). Evidence for gene transfer and expression of factor IX in hemophilia B patients treated with an AAV vector. Nat. Genet. 23, 257-261.
26. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., MCQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTZMAN, G.J., and BYRNE, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
27. KOEBERL, D.D., ALEXANDER, I.E., HALBERT, C.L., RUSSELL, D.W., and MILLER, A.D. (1997). Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 94, 1426-1431.
28. KUBE, D.M., and SRIVASTAVA, A. (1997). Quantitative DNA slot blot analysis: Inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res. 25, 3375-3376.
29. KUBE, D.M., PONNAZHAGAN, S., and SRIVASTAVA, A. (1997). Encapsidation of adeno-associated virus type 2 Rep proteins in wildtype and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J. Virol. 71, 7361-7371.
30. LAFACE, D., HERMONAT, P., WAKELAND, E., and PECK, A. (1988). Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162, 483-486.
31. LORENZEN, J.A., DADABAY, C.Y., and FISCHER, E.H. (1995). COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J. Cell Biol. 131, 631-643.
32. MAH, C., QING, K., KHUNTIRAT, B., PONNAZHAGAN, S., WANG, X.S., KUBE, D.M., YODER, M.C., and SRIVASTAVA, A. (1998). Adeno-associated virus 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J. Virol. 72, 9835-9843.
33. MAH, C., QING, K., HANSEN, J., KHUNTRIRAT, B., YODER, M.C., and SRIVASTAVA, A. (1999). Gene transfer with adeno-associated virus 2 vectors: The growth factor receptor connection. Gene Ther. Mol. Biol. 3, 57-65.
34. MALIK, P., MCQUISTON, S.A., YU, X.J., PEPPER, K.A., KRALL, W.J., PODSAKOFF, G.M., KURTZMAN, G.J., and KOHN, D.B. (1997). Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in K562 human hematopoietic cell line. J. Virol. 71, 1776-1783.
35. MANNO, C.S., CHEW, A.J., HUTCHISON, S., LARSON, P.J., HERZOG, R.W., ARRUDA, V.R., TAI, S.J., RAGNI, M.V., THOMPSON, A., OZELO, M., COUTO, L.B., LEONARD, D.G., JOHNSON, F.A., MCCLELLAND, A., SCALLAN, C., SKARSGARD, E., FLAKE, A.W., KAY, M.A., HIGH, K.A., and GLADER, B. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963-2972.
36. MCCOWN, T.J., XIAO, X., LI, J., BREESE, G.R., and SAMULSKI, R.J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99-107.
37. MILLER, J.L., DONAHUE, R.E., SELLERS, S.E., SAMULSKI, R.J., YOUNG, N.S., and NIENHUIS, A.W. (1994). Recombinant adenoassociated virus (rAAV)-mediated expression of a human γ-globin gene in human progenitor-derived erythroid. Proc. Natl. Acad. Sci. U.S.A. 91, 10183-10187.
38. MIYATA, Y., CHAMBRAUD, B., RADANYI, C., LECLERC, J., LEBEAU, M.C., RENOIR, J.M., SHIRAI, R., CATELLI, M.G., YAHARA, I., and BAULIEU, E.E. (1997). Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: Regulation of HSP90-binding activity of FKBP52. Proc. Natl. Acad. Sci. U.S.A. 94, 14500-14505.
39. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
40. - subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Ther. 7, 183-195.
41. PING, P., YANG, Q., and HAMMOND, H.K. (1996). Altered β-adrenergic receptor signaling in heart failure, in vivo gene transfer via adeno and adeno-associated virus. Microcirculation 3, 225-228.
42. PONNAZHAGAN, S., NALLARI, M.L., and SRIVASTAVA, A. (1994). Suppression of human α-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J. Exp. Med. 179, 733-738.
43. + hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation. J. Virol. 71, 8262-8267.
44. PONNAZHAGAN, S., MUKHERJEE, P., YODER, M.C., WANG, X.S., ZHOU, S.Z., KAPLAN, J., WADSWORTH, S., and SRIVASTAVA, A. (1997b). Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice. Gene 190, 203-210.
45. PONNAZHAGAN, S., YODER, M.C., and SRIVASTAVA, A. (1997c). Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J. Virol. 71, 3098-3104.
46. PRATT, W.B. (1998). The hsp90-based chaperone system: Involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med. 217, 420-434.
47. PRATT, W.B., and TOFT, D.O. (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrinol. Rev. 18, 306-360.
48. cdc37. Cell. Signal. 11, 839-851.
49. QING, K., WANG, X.S., KUBE, D.M., PONNAZHAGAN, S., BAJPAI, A., and SRIVASTAVA, A. (1997). Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 10879-10884.
50. QING, K., KHUNTIRAT, B., MAH, C., KUBE, D.M., WANG, X.S., PONNAZHAGAN, S., ZHOU, S., DWARKI, V.J., YODER, M.C., and SRIVASTAVA, A. (1998). Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72, 1593-1599.
51. QING, K., MAH, C., HANSEN, J., ZHOU, S., DWARKI, V., and SRIVASTAVA, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71-77.
52. QING, K., HANSEN, J., WEIGEL-KELLEY, K.A., TAN, M., ZHOU, S., and SRIVASTAVA, A. (2001). Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J. Virol. 75, 8968-8976.
53. QING, K., LI, W., ZHONG, L., TAN, M., HANSEN, J., WEIGEL-KELLEY, K.A., CHEN, L., YODER, M.C., and SRIVASTAVA, A. (2003). Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J. Virol. 77, 2741-2746.
54. SANLIOGLU, S., BENSON, P.K., YANG, J., ATKINSON, E.M., REYNOLDS, T., and ENGELHARDT, J.F. (2000). Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74, 9184-9196.
55. SCHLATTER, H., LANGER, T., ROSMUS, S., ONNEKEN, M.L., and FASOLD, H. (2002). A novel function for the 90 kDa heat-shock protein (Hsp90): Facilitating nuclear export of 60 S ribosomal subunits. Biochem. J. 362, 675-684.
56. SEISENBERGER, G., RIED, M.U., ENDRESS, T., BUNING, H., HALLEK, M., and BRAUCHLE, C. (2001). Real-time single-molecule imaging of the infection pathway of an adeno-associated virus. Science 294, 1929-1932.
57. SNYDER, R.O., MIAO, C.H., PATIJN, G.A., SPRATT, S.K., DANOS, O., NAGY, D., GOWN, A.M., WINTHER, B., MEUSE, L., COHEN, L.K., THOMPSON, A.R., and KAY, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270-276.
58. SRIVASTAVA, A., WANG, X.S., PONNAZHAGAN, S., ZHOU, S.Z., and YODER, M.C. (1996). Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells. Curr. Top. Microbiol. Immunol. 218, 93-117.
59. SUMMERFORD, C., and SAMULSKI, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
60. vβ5 integrin: A co-receptor for adeno-associated virus 2 infection. Nat. Med. 5, 78-82.
61. TAN, M., QING, K., ZHOU, S., YODER, M.C., and SRIVASTAVA, A. (2001). Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human β-globin gene in hematopoietic cells from homozygous beta-thalassemic mice. Mol. Ther. 3, 940-946.
62. THOMAS, C.E., STORM, T.A., HUANG, Z., and KAY, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122.
63. WAGNER, J.A., NEPOMUCENO, I.B., MESSNER, A.H., MORAN, M.L., BATSON, E.P., DIMICELI, S., BROWN, B.W., DESCH, J.K., NORBASH, A.M., CONRAD, C.K., GUGGINO, W.B., FLOTTE, T.R., WINE, J.J., CARTER, B.J., REYNOLDS, T.C., MOSS, R.B., and GARDNER, P. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13, 1349-1359.
64. WALSH, C.E., LIU, J.M., XIAO, X., YOUNG, N.S., NIENHUIS, A.W., and SAMULSKI, R.I. (1992). Regulated high level expression of a human γ-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 89, 7257-7261.
65. WALSH, C.E., LIU, J.M., MILLER, J.L., NIENHUIS, A.W., and SAMULSKI, R.J. (1993). Gene therapy for human hemoglobinopathies. Proc. Soc. Exp. Biol. Med. 204, 289-300.
66. WANG, X.S., PONNAZHAGAN, S., and SRIVASTAVA, A. (1996). Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions. J. Virol. 70, 1668-1677.
67. WANG, X.S., QING, K., PONNAZHAGAN, S., and SRIVASTAVA, A. (1997). Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats. J. Virol. 71, 3077-3082.
68. XIAO, W., WARRINGTON, K.H., JR., HEARING, P., HUGHES, J., and MUZYCZKA, N. (2002). Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J. Virol. 76, 11505-11517.
69. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adenoassociated virus vector. J. Virol. 70, 8098-8108.
70. YOU-TEN, K.E., MUISE, E.S., ITIE, A., MICHALISZYN, E., WAGNER, J., JOTHY, S., LAPP, W.S., and TREMBLAY, M.L. (1997). Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J. Exp. Med. 186, 683-693.
71. ZHONG, L., LI, W., YANG, Z., CHEN, L., LI, Y., QING, K., WEIGEL-KELLEY, K.A., YODER, M.C., SHOU, W., and SRIVASTAVA, A. (2004a). Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo. Gene Ther. 11, 1165-1169.
72. ZHONG, L., QING, K., SI, Y., CHEN, L., TAN, M., and SRIVASTAVA, A. (2004b). Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90. J. Biol. Chem. 279, 12714-12723.
73. ZHOU, S.Z., BROXMEYER, H.E., COOPER, S., HARRINGTON, M.A., and SRIVASTAVA, A. (1993). Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp. Hematol. 21, 928-933.
74. ZHOU, S.Z., LI, Q., STAMATOYANNOPOULOS, G., and SRIVASTAVA, A. (1996). Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human β-globin gene. Gene Ther. 3, 223-229.